REQUEST A DEMO
Total
USD $0.00
Search more companies

Arxada Biotec S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Other Chemical Product and Preparation Manufacturing
Full name: Arxada Biotec S.R.O. Profile Updated: March 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

LONZA BIOTEC s. r. o. is a part of Lonza, one of the world's suppliers to the pharmaceutical industry, health and biotechnology. The company is based in Kourim and specializes in the production of starting materials for pharmaceuticals, specialized nutritional supplements for human nutrition and animal nutrition and products improving crop yields and food quality.

Headquarters
Okruzni 134
Kourim; Stredocesky; Postal Code: 28161

Contact Details: Purchase the Arxada Biotec S.R.O. report to view the information.

Website: https://www.lonza.com/cz

Basic Information
Total Employees:
Purchase the Arxada Biotec S.R.O. report to view the information.
Outstanding Shares:
Purchase the Arxada Biotec S.R.O. report to view the information.
Registered Capital:
Purchase the Arxada Biotec S.R.O. report to view the information.
Financial Auditors:
Purchase the Arxada Biotec S.R.O. report to view the information.
Incorporation Date:
April 27, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Arxada Biotec S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
37.02%
Total operating revenue
33.96%
Operating profit (EBIT)
-96.1%
EBITDA
-35.48%
Net Profit (Loss) for the Period
-72.58%
Total assets
19.47%
Total equity
1.48%
Operating Profit Margin (ROS)
-10.49%
Net Profit Margin
-6.84%
Return on Equity (ROE)
-3.94%
Quick Ratio
-1.18%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?